AI and Big Data in Oncology: A Physician‐Centered Perspective on Emerging Clinical and Research Applications
The convergence of artificial intelligence (AI) and big data is reshaping contemporary oncology by enabling the integration of multimodal information across imaging, pathology, genomics, and clinical records. From a physician-centered perspective, these technologies can potentially be used to improve diagnostic precision, support individualized treatment planning, enhance longitudinal patient management, and accelerate both clinical and translational research. In this review, we synthesize the core AI methodologies most relevant to oncology-machine learning, deep learning, and large language models-and examine how they interact with established and emerging oncology data platforms. We further highlight practical use cases in clinical workflows and research pipelines, emphasizing opportunities for advancing precision cancer care while also addressing challenges associated with data heterogeneity, model generalizability, privacy protection, and real-world implementation. By underscoring the synergistic value of AI and big data, this review aims to inform the development of clinically meaningful, context-adapted strategies that promote translational innovation in both global and locally resourced healthcare environments.
Authors
- Qingyao Shang
- Binliang Liu (ORCID: https://orcid.org/0000-0002-3692-2272)
- Jun Li (ORCID: https://orcid.org/0000-0002-1336-2241)
- Q. Ouyang
- Meishuo Ouyang
- Shuna Yao
- Yu Wang
- Sheng Luo
Institutions
- University of Notre Dame (US)
- Louisiana State University (US)
- Central South University (CN)
- Duke University (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Hunan Cancer Hospital (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1002/cai2.70047
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00